Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKesson
AstraZeneca
Express Scripts
Johnson and Johnson
Mallinckrodt
McKinsey

Last Updated: October 23, 2019

DrugPatentWatch Database Preview

BUTABARB Drug Profile

See Plans and Pricing

« Back to Dashboard

Summary for BUTABARB
Drug patent expirations by year for BUTABARB
Synonyms for BUTABARB
125-40-6
2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(1-methylpropyl)-
2,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(1-methylpropyl)-
5-(butan-2-yl)-5-ethyl-1,3-diazinane-2,4,6-trione
5-(butan-2-yl)-5-ethyl-4,6-dihydroxy-2,5-dihydropyrimidin-2-one
5-(butan-2-yl)-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione
5-butan-2-yl-5-ethyl-1,3-diazinane-2,4,6-trione
5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione
5-Ethyl-5-(1-methylpropyl)barbiturate
5-Ethyl-5-(1-methylpropyl)barbituric acid
5-ethyl-5-(1-methylpropyl)pyrimidine-2,4,6(1H,3H,5H)-trione
5-Ethyl-5-isobutylbarbituric acid
5-ethyl-5-sec-butyl-barbituric acid
5-ethyl-5-sec-butyl-hexahydropyrimidine-2,4,6-trione
5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione
5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione #
5-SEC-BUTYL-5-ETHYL-BARBITURIC ACID
5-sec-Butyl-5-ethylbarbituric acid
5-sec-Butyl-5-ethylmalonyl urea
5-sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione
97164-73-3
AC-16078
AC1L1DRT
AKOS015962208
AN-22964
API0004766
Barbituric acid, 5-ethyl-5-isobutyl-
Barbituric acid, 5-sec-butyl-5-ethyl-
BRN 0199127
BRN 0199734
butabarbital
Butabarbital (USP)
Butabarbital (VAN)
Butabarbital [USAN]
Butabarbital [USP]
Butabarbital |||5-sec-Butyl-5-ethylbarbituric acid
BUTABARBITAL SODIUM
Butabarbital solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material
Butabarbitone
Butalan
Butatab
Butatal
Buticaps
Butisol
Butisol sodium
Butrate
C07827
CHEBI:3228
CHEMBL449
CS-7224
D03180
DB00237
DTXSID2022709
EINECS 204-738-6
FT-0663911
GTPL7137
HSDB 3018
HY-U00167
LS-23930
LS-24330
Medarsed
Nilox
NSC 27517
NSC-27517
NSC27517
Pyridium plus (Salt/Mix)
SCHEMBL79254
sec-Butobarbitone
Secbubarbital
Secbutabarbital
Secbutabarbital (BAN)
Secbutabarbital [INN:BAN]
Secbutabarbital [INN]
Secbutabarbitale
Secbutabarbitale [DCIT]
Secbutabarbitalum
Secbutabarbitalum [INN-Latin]
Secbutobarbital
Secbutobarbitone
Sodium butabarbital
Unicelles
WLN: T6VMVMV FHJ FY2 & 1 F2
ZRIHAIZYIMGOAB-UHFFFAOYSA-N

US Patents and Regulatory Information for BUTABARB

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alpharma Us Pharms BUTABARB butabarbital sodium ELIXIR;ORAL 085873-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Sandoz BUTABARBITAL SODIUM butabarbital sodium TABLET;ORAL 085934-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Sandoz BUTABARBITAL SODIUM butabarbital sodium TABLET;ORAL 084292-003 Feb 9, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Teva BUTABARBITAL SODIUM butabarbital sodium TABLET;ORAL 088632-001 May 18, 1985 DISCN No No   Start Trial   Start Trial   Start Trial
Solvay BUTABARBITAL SODIUM butabarbital sodium TABLET;ORAL 083606-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Whiteworth Town Plsn BUTABARBITAL SODIUM butabarbital sodium TABLET;ORAL 083325-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs BUTABARBITAL SODIUM butabarbital sodium TABLET;ORAL 085764-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
AstraZeneca
Colorcon
Moodys
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.